GoodRx Holdings, Inc.

NasdaqGS GDRX

GoodRx Holdings, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2024: USD -66.58 M

GoodRx Holdings, Inc. Capital Expenditure is USD -66.58 M for the Trailing 12 Months (TTM) ending September 30, 2024, a -14.42% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • GoodRx Holdings, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2023 was USD -58.18 M, a -18.30% change year over year.
  • GoodRx Holdings, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2022 was USD -49.18 M, a -40.49% change year over year.
  • GoodRx Holdings, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -35.01 M, a -26.00% change year over year.
  • GoodRx Holdings, Inc. Capital Expenditure for the Trailing 12 Months (TTM) ending September 30, 2020 was USD -27.78 M.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
Loading...
SV Wall Street
NasdaqGS: GDRX

GoodRx Holdings, Inc.

CEO Ms. Wendy Barnes
IPO Date Sept. 23, 2020
Location United States
Headquarters 2701 Olympic Boulevard
Employees 694
Sector Healthcare
Industries
Description

GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. It serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. The company was incorporated in 2015 and is headquartered in Santa Monica, California.

Similar companies

TALK

Talkspace, Inc.

USD 3.16

1.93%

PRVA

Privia Health Group, Inc.

USD 22.90

0.22%

SLP

Simulations Plus, Inc.

USD 34.15

-0.50%

TDOC

Teladoc Health, Inc.

USD 10.05

-1.08%

EVH

Evolent Health, Inc.

USD 10.21

-2.30%

NRC

National Research Corporation

USD 16.36

-1.86%

CERT

Certara, Inc.

USD 13.98

-1.76%

AMWL

American Well Corporation

USD 10.79

0.09%

DH

Definitive Healthcare Corp.

USD 4.75

-2.26%

PGNY

Progyny, Inc.

USD 23.60

1.86%

HSTM

HealthStream, Inc.

USD 32.79

0.43%

HCAT

Health Catalyst, Inc.

USD 5.47

-2.84%

SDGR

Schrödinger, Inc.

USD 24.72

-1.44%

ACCD

Accolade, Inc.

USD 6.94

0.73%

GEHC

GE HealthCare Technologies Inc.

USD 87.51

-0.90%

VEEV

Veeva Systems Inc.

USD 233.29

0.01%

TXG

10x Genomics, Inc.

USD 14.45

-3.67%

DOCS

Doximity, Inc.

USD 59.10

0.00%

StockViz Staff

February 4, 2025

Any question? Send us an email